Stay updated with breaking news from Patrickr Oneil. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
AtonRa Partners reduced its position in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Rating) by 21.3% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 13,875 shares of the company’s stock after selling 3,753 shares during the period. AtonRa Partners’ holdings in […]
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Rating) has received a consensus rating of “Hold” from the thirteen brokerages that are currently covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, four have given a hold rating and five have issued a buy rating on the company. The average […]
Wall Street analysts forecast that Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Rating) will post sales of $145.04 million for the current fiscal quarter, according to Zacks. Eight analysts have made estimates for Ionis Pharmaceuticals’ earnings, with the lowest sales estimate coming in at $107.00 million and the highest estimate coming in at $193.90 million. Ionis […]
Wall Street brokerages forecast that Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Rating) will report earnings per share (EPS) of ($0.62) for the current fiscal quarter, according to Zacks. Eight analysts have made estimates for Ionis Pharmaceuticals’ earnings, with the lowest EPS estimate coming in at ($0.77) and the highest estimate coming in at ($0.31). Ionis […]
Shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Rating) have been assigned an average recommendation of “Hold” from the twelve brokerages that are currently covering the firm, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a sell rating, two have assigned a hold rating and five have issued a buy rating […]